{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:52:20Z","timestamp":1789447940104,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.socscimed.2021.113986","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:44:14Z","timestamp":1620045854000},"page":"113986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["\u201cPeople need them or else they're going to take fentanyl and die\u201d: A qualitative study examining the \u2018problem\u2019 of prescription opioid diversion during an overdose epidemic"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3368-7681","authenticated-orcid":false,"given":"Geoff","family":"Bardwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lavalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib1","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1331\/JAPhA.2014.13101","article-title":"Pharmacists' role in addressing opioid abuse, addiction, and diversion","volume":"54","year":"2014","journal-title":"J. Am.. Pharm. Assoc. (2003)"},{"key":"10.1016\/j.socscimed.2021.113986_bib2","doi-asserted-by":"crossref","first-page":"100288","DOI":"10.1016\/j.sste.2019.100288","article-title":"Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: a spatial analysis","volume":"30","author":"Amram","year":"2019","journal-title":"Spat. Spatio-temporal Epidemiol."},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12954-019-0354-y","article-title":"Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances","volume":"17","author":"Andersson","year":"2020","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.socscimed.2021.113986_bib4","series-title":"Analysing Policy: What's the Problem Represented to Be? Frenchs Forest","author":"Bacchi","year":"2009"},{"key":"10.1016\/j.socscimed.2021.113986_bib5","series-title":"Engaging with Carol Bacchi: Strategic Interventions and Exchanges","first-page":"21","article-title":"Introducing the \u2018What's the Problem Represented to be?\u2019 approach","author":"Bacchi","year":"2012"},{"key":"10.1016\/j.socscimed.2021.113986_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugpo.2018.02.004","article-title":"The perspectives of structurally vulnerable people who use drugs on volunteer stipends and work experiences provided through a drug user organization: opportunities and limitations","volume":"55","author":"Bardwell","year":"2018","journal-title":"Int. J. Drug Pol."},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10550887.2020.1718264","article-title":"HIV and drug related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis","volume":"38","author":"Bayat","year":"2020","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.socscimed.2021.113986_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today's fentanyl crisis: prohibition's Iron Law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"Int. J. Drug Pol."},{"issue":"5","key":"10.1016\/j.socscimed.2021.113986_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","article-title":"Addressing the syndemic of HIV, Hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply","volume":"81","author":"Bonn","year":"2020","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"11","key":"10.1016\/j.socscimed.2021.113986_bib10","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3109\/10826089809056260","article-title":"The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments","volume":"33","author":"Bourgois","year":"1998","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1005574918294","article-title":"Disciplining addictions: the bio-politics of methadone and heroin in the United States","volume":"24","author":"Bourgois","year":"2000","journal-title":"Cult. Med. Psychiatry"},{"issue":"4","key":"10.1016\/j.socscimed.2021.113986_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/09581596.2015.1007923","article-title":"Policing 'Vancouver's mental health crisis': a critical discourse analysis","volume":"26","author":"Boyd","year":"2016","journal-title":"Crit. Publ. Health"},{"key":"10.1016\/j.socscimed.2021.113986_bib13","series-title":"Fentanyl-detected Illicit Drug Toxicity Deaths: January 1, 2012 to May 31, 2020","author":"British Columbia Coroners Service","year":"2020"},{"key":"10.1016\/j.socscimed.2021.113986_bib14","series-title":"Safe Supply: Concept Document","year":"2019"},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pmn.2019.07.001","article-title":"State boards of nursing guidance to mitigate prescription opioid misuse and diversion","volume":"21","author":"Carlson","year":"2020","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.socscimed.2021.113986_bib16","doi-asserted-by":"crossref","first-page":"102722","DOI":"10.1016\/j.drugpo.2020.102722","article-title":"Unintentional drug overdose: is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?","volume":"79","author":"Carlson","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000436","article-title":"The more things change: buprenorphine\/naloxone diversion continues while treatment remains inaccessible","volume":"12","author":"Carroll","year":"2018","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2021.113986_bib19","series-title":"Professional Standards and Gudelines: Safe Prescribing of Drugs with Potential for Misuse\/Diversion","author":"College of Physicians and Surgeons of British Columbia","year":"2016"},{"key":"10.1016\/j.socscimed.2021.113986_bib20","series-title":"Questions and Answers about the College's Newly Revised Professional Standard: Safe Prescribing of Drugs with Potential for Misuse\/Diversion","author":"College of Physicians and Surgeons of British Columbia","year":"2016"},{"issue":"11","key":"10.1016\/j.socscimed.2021.113986_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7326\/M18-0883","article-title":"Prescription drug monitoring programs: promising practices in need of refinement","volume":"168","author":"Compton","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2015.04.003","article-title":"Prescription opioid abuse: problems and responses","volume":"80","author":"Compton","year":"2015","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0277-9536(92)90187-U","article-title":"Risk perception, risk taking and risk management among intravenous drug users: implications for AIDS prevention","volume":"34","author":"Connors","year":"1992","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib24","series-title":"Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory","author":"Corbin","year":"2015"},{"key":"10.1016\/j.socscimed.2021.113986_bib25","series-title":"Illicit Drug Toxicity Deaths in BC: January 1, 2010 - December 31, 2020","author":"Coroners Service","year":"2021"},{"issue":"1\u20133","key":"10.1016\/j.socscimed.2021.113986_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2007.08.008","article-title":"Prescription opioid use, misuse, and diversion among street drug users in New York City","volume":"92","author":"Davis","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1073110520935353","article-title":"Decriminalization of diverted buprenorphine in Burlington, Vermont and Philadelphia: an intervention to reduce opioid overdose deaths","volume":"48","author":"del Pozo","year":"2020","journal-title":"J. Law Med. Ethics"},{"key":"10.1016\/j.socscimed.2021.113986_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7517-9-3","article-title":"The nature of methadone diversion in England: a Merseyside case study","volume":"9","author":"Duffy","year":"2012","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.socscimed.2021.113986_bib29","doi-asserted-by":"crossref","first-page":"102479","DOI":"10.1016\/j.drugpo.2019.05.022","article-title":"Producing the \u2018problem\u2019 of new psychoactive substances (NPS) in English prisons","volume":"80","author":"Duke","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15332641003772611","article-title":"Macro-level social forces and micro-level consequences: poverty, alternate occupations, and drug dealing","volume":"9","author":"Dunlap","year":"2010","journal-title":"J. Ethn. Subst. Abuse"},{"key":"10.1016\/j.socscimed.2021.113986_bib31","doi-asserted-by":"crossref","first-page":"102450","DOI":"10.1016\/j.drugpo.2019.04.007","article-title":"'It's good being part of the community and doing the right thing': (Re)problematising 'community' in new recovery-oriented policy and consumer accounts","volume":"80","author":"Fomiatti","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"7","key":"10.1016\/j.socscimed.2021.113986_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1615145","article-title":"Addressing the fentanyl threat to public health","volume":"376","author":"Frank","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.drugpo.2011.09.004","article-title":"Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia","volume":"22","author":"Fraser","year":"2011","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2021.113986_bib34","series-title":"Habits: Remaking Addiction","first-page":"91","article-title":"Making methamphetamine in drug policy and consumer accounts","author":"Fraser","year":"2014"},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","article-title":"Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups","volume":"18","author":"Friedman","year":"2007","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2021.113986_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2019.04.022","article-title":"Opioid-related deaths and previous care for drug use and pain relief in Sweden","volume":"201","author":"Fugelstad","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.socscimed.2021.113986_bib37","doi-asserted-by":"crossref","first-page":"102922","DOI":"10.1016\/j.drugpo.2020.102922","article-title":"\u2018Peer\u2019 work as precarious: a qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work","volume":"85","author":"Greer","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"9","key":"10.1016\/j.socscimed.2021.113986_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.2014.18514","article-title":"Mandatory use of prescription drug monitoring programs","volume":"313","author":"Haffajee","year":"2015","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1377\/hlthaff.2017.1321","article-title":"Four States with robust prescription drug monitoring programs reduced opioid dosages","volume":"37","author":"Haffajee","year":"2018","journal-title":"Health Aff."},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib40","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","article-title":"Methadone diversion as a protective strategy: the harm reduction potential of \u2018generous constraints\u2019","volume":"24","author":"Harris","year":"2013","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2021.113986_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7517-10-24","article-title":"Diversion' of methadone or buprenorphine: 'harm' versus 'helping'","volume":"10","author":"Havnes","year":"2013","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.socscimed.2021.113986_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.29173\/mlj1012","article-title":"A bad deal: British Columbia's emphasis on deterrence and increasing prison sentences for street-level fentanyl traffickers","volume":"149","author":"Hrymak","year":"2018","journal-title":"Manitoba Law J."},{"key":"10.1016\/j.socscimed.2021.113986_bib43","doi-asserted-by":"crossref","first-page":"102769","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: the role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2021.113986_bib44","doi-asserted-by":"crossref","first-page":"108202","DOI":"10.1016\/j.drugalcdep.2020.108202","article-title":"Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study","author":"Ivsins","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10550887.2014.975617","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication","volume":"34","author":"Johnson","year":"2015","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.socscimed.2021.113986_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2015.01.013","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms","volume":"54","author":"Johnson","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15360288.2015.1037521","article-title":"The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response","volume":"29","author":"Kanouse","year":"2015","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"9","key":"10.1016\/j.socscimed.2021.113986_bib48","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamainternmed.2019.1064","article-title":"Association of opioid overdose with opioid prescriptions to family members","volume":"179","author":"Khan","year":"2019","journal-title":"JAMA Internal Med."},{"issue":"8","key":"10.1016\/j.socscimed.2021.113986_bib49","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review","volume":"104","author":"King","year":"2014","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.socscimed.2021.113986_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugpo.2017.07.020","article-title":"Making medicine; producing pleasure: a critical examination of medicinal cannabis policy and law in Victoria, Australia","volume":"49","author":"Lancaster","year":"2017","journal-title":"Int. J. Drug Pol."},{"issue":"9","key":"10.1016\/j.socscimed.2021.113986_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.drugpo.2015.03.007","article-title":"Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients","volume":"26","author":"Launonen","year":"2015","journal-title":"Int. J. Drug Pol."},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13501789700000006","article-title":"Situated rationality","volume":"4","author":"Lawson","year":"1997","journal-title":"J. Econ. Methodol."},{"issue":"3","key":"10.1016\/j.socscimed.2021.113986_bib53","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.addbeh.2006.05.022","article-title":"Motives, diversion and routes of administration associated with nonmedical use of prescription opioids","volume":"32","author":"McCabe","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.socscimed.2021.113986_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","article-title":"\u2018Safer Environment Interventions\u2019: a qualitative synthesis of the experiences and perceptions of people who inject drugs","volume":"106","author":"McNeil","year":"2014","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.socscimed.2015.04.008","article-title":"Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: a qualitative study","volume":"133","author":"McNeil","year":"2015","journal-title":"Soc. Sci. Med."},{"issue":"7","key":"10.1016\/j.socscimed.2021.113986_bib56","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.socscimed.2004.01.029","article-title":"Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia","volume":"59","author":"Moore","year":"2004","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib57","series-title":"Overdose Death Rates","year":"2018"},{"key":"10.1016\/j.socscimed.2021.113986_bib58","series-title":"Opioid Overdose Crisis","year":"2020"},{"key":"10.1016\/j.socscimed.2021.113986_bib59","series-title":"Habitus and Drug Using Environments: Health, Place and Lived-Experience","author":"Parkin","year":"2016"},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/14461242.2015.1008537","article-title":"Locating and applying sociological theories of risk-taking to develop public health interventions for adolescents","volume":"24","author":"Pound","year":"2015","journal-title":"Health Sociol. Rev. : J. Health Sec. Aust. Sociol. Assoc."},{"key":"10.1016\/j.socscimed.2021.113986_bib61","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.jhealeco.2019.102286","article-title":"How increasing medical access to opioids contributes to the opioid epidemic: evidence from Medicare Part D","volume":"71","author":"Powell","year":"2020","journal-title":"J. Health Econ."},{"issue":"3","key":"10.1016\/j.socscimed.2021.113986_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/1467-9566.ep10934410","article-title":"Risk theory in epidemic times: sex, drugs and the social organisation of \u2018risk behaviour\u2019","volume":"19","author":"Rhodes","year":"1997","journal-title":"Sociol. Health Illness"},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0277-9536(02)00521-X","article-title":"Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment","volume":"57","author":"Rhodes","year":"2003","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2021.113986_bib65","series-title":"Rethinking Social Epidemiology: towards a Science of Change","first-page":"205","article-title":"Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection drug users and sex workers","author":"Rhodes","year":"2012"},{"issue":"1","key":"10.1016\/j.socscimed.2021.113986_bib66","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12913-019-4642-8","article-title":"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review","volume":"19","author":"Rhodes","year":"2019","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"10.1016\/j.socscimed.2021.113986_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jsat.2011.12.008","article-title":"Addiction treatment-related employment barriers: the impact of methadone maintenance","volume":"43","author":"Richardson","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"issue":"7","key":"10.1016\/j.socscimed.2021.113986_bib68","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jech-2014-205079","article-title":"Socioeconomic marginalisation in the structural production of vulnerability to violence among people who use illicit drugs","volume":"69","author":"Richardson","year":"2015","journal-title":"J. Epidemiol. Community Health"},{"issue":"4","key":"10.1016\/j.socscimed.2021.113986_bib69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/002204268601600406","article-title":"Methadone diversion: a new look","volume":"16","author":"Spunt","year":"1986","journal-title":"J. Drug Issues"},{"issue":"8","key":"10.1016\/j.socscimed.2021.113986_bib70","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","article-title":"Needle exchange is not enough: lessons from the Vancouver injecting drug use study","volume":"11","author":"Strathdee","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.socscimed.2021.113986_bib71","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2017"},{"issue":"34","key":"10.1016\/j.socscimed.2021.113986_bib72","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1503\/cmaj.201618","article-title":"A safer drug supply: a pragmatic and ethical response to the overdose crisis","volume":"192","author":"Tyndall","year":"2020","journal-title":"Can. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am. J. Publ. Health"},{"issue":"2","key":"10.1016\/j.socscimed.2021.113986_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/dar.12226","article-title":"Denial of prescription analgesia among people who inject drugs in a Canadian setting","volume":"34","author":"Voon","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.socscimed.2021.113986_bib75","doi-asserted-by":"crossref","first-page":"102538","DOI":"10.1016\/j.drugpo.2019.07.033","article-title":"Potential issues of morbidity, toxicity and dependence': problematizing the up-scheduling of over-the-counter codeine in Australia","volume":"80","author":"Weier","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"6","key":"10.1016\/j.socscimed.2021.113986_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int. J. Drug Pol."},{"issue":"7","key":"10.1016\/j.socscimed.2021.113986_bib77","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"Wood","year":"2003","journal-title":"CMAJ (Can. Med. Assoc. J.)"}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027795362100318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027795362100318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:37:38Z","timestamp":1759505858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027795362100318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":77,"alternative-id":["S027795362100318X"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2021.113986","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cPeople need them or else they're going to take fentanyl and die\u201d: A qualitative study examining the \u2018problem\u2019 of prescription opioid diversion during an overdose epidemic","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2021.113986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113986"}}